Atrosimab
Atrosimab (ATM-001) is a Fv-Fc1κ fusion protein with strong binding to human TNFR1 with an EC50 value of 0.37 nM. Atrosimab potently inhibits TNF-induced activation of TNFR1. Atrosimab has the potential for the study of chronic inflammatory diseases[1].
Product Specifications
Product Name Alternative
ATM-001
UNSPSC
12352203
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
99
Smiles
[Atrosimab]
Molecular Weight
(72.338 kDa)
References & Citations
[1]Richter F, et al. Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing Fc. MAbs. 2019 May/Jun;11 (4) :653-665.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0048500-01 20 µL
Polyclonal Antibody to Fc Fragment Of IgG Low Affinity IIIa Receptor (FcgR3A)
Sign In for Pricing
View Details TRV-0048500-02 100 µL
Polyclonal Antibody to Fc Fragment Of IgG Low Affinity IIIa Receptor (FcgR3A)
Sign In for Pricing
View Details TRV-0048500-03 200 µL
Polyclonal Antibody to Fc Fragment Of IgG Low Affinity IIIa Receptor (FcgR3A)
Sign In for Pricing
View Details TRV-0048500-04 1 mL
Polyclonal Antibody to Fc Fragment Of IgG Low Affinity IIIa Receptor (FcgR3A)
Sign In for Pricing
View Details 038001-ML550 100 µL
LST1, ID (LST1, B144, Leukocyte-specific transcript 1 protein, Protein B144) (MaxLight 550) discontinued
Sign In for Pricing
View Details 